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Abstract
Several genetic and non-genetic factors have been shown to increase the risk for developing Alzheimer’s
disease (AD). Alcohol consumption has been examined as one factor that may increase risk for AD in heavy
drinkers and decrease risk for light to moderate drinkers. Given the potential interaction between alcohol use
history and other risk factors, the current study evaluated the moderating effect of alcohol consumption on
specific risk factors for AD, including history of hypertension, hyperlipidemia, type 2 diabetes, and presence
of ApoE-e4 allele. In this cross-sectional study, participants included 299 community-dwelling older adults,
aged 65-88, with possible or probable AD, who were enrolled as research subjects or clinical patients at an
aging and Alzheimer’s disease clinic. History of diabetes was significantly skewed and kurtotic and removed
from the final analysis. Results indicated that certain sociodemographic factors were positively predictive of
lower age of AD onset. History of hyperlipidemia was significant for predicting lower age of onset of AD, but
could reflect an age-related finding. Alcohol use was shown to moderate the relationship between history of
hypertension and age of onset of AD, suggesting that low to moderate alcohol use may serve as a protective
factor for individuals with a history of hypertension. Future directions and limitations of study findings are
also discussed.
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Abstract 
 
Several genetic and non-genetic factors have been shown to increase the risk for developing 
Alzheimer’s disease (AD). Alcohol consumption has been examined as one factor that may 
increase risk for AD in heavy drinkers and decrease risk for light to moderate drinkers. Given the 
potential interaction between alcohol use history and other risk factors, the current study 
evaluated the moderating effect of alcohol consumption on specific risk factors for AD, 
including history of hypertension, hyperlipidemia, type 2 diabetes, and presence of ApoE-ε4 
allele. In this cross-sectional study, participants included 299 community-dwelling older adults, 
aged 65-88, with possible or probable AD, who were enrolled as research subjects or clinical 
patients at an aging and Alzheimer’s disease clinic.  History of diabetes was significantly skewed 
and kurtotic and removed from the final analysis. Results indicated that certain 
sociodemographic factors were positively predictive of lower age of AD onset. History of 
hyperlipidemia was significant for predicting lower age of onset of AD, but could reflect an age-
related finding.  Alcohol use was shown to moderate the relationship between history of 
hypertension and age of onset of AD, suggesting that low to moderate alcohol use may serve as a 
protective factor for individuals with a history of hypertension. Future directions and limitations 
of study findings are also discussed.
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Alzheimer’s disease (AD) is a neurodegenerative disorder that involves the deterioration 
of cognitive and functional abilities, along with changes in behavior and personality. Although 
significant advances have been made over the years with respect to early detection of symptoms, 
there is still no agreed upon cause, and the number of individuals diagnosed continues to increase 
(Alzheimer’s Association, 2013). In order to better understand AD progression and improve 
patient care, a number of risk factors have been identified.  Certain factors such as age, gender, 
education, dementia severity and apolipoprotein E (ApoE) genotype and have been identified as 
predictors of cognitive decline and incident dementia, however, these results have been 
inconsistent across studies (Teri, McCurry, Edland, Kukull, & Larson, 1995; Lobo et al., 2010; 
Suh, Ju, Yeon, & Shah, 2004).  
 Alcohol consumption has been examined as a protective factor and also as a risk factor 
for cognitive decline and incident AD. When reporting alcohol consumption levels, most studies 
have grouped individuals as abstainers, mild or moderate drinkers, or heavy drinkers. Findings 
from community- and cohort-based studies have identified a u-shaped or j-shaped curvilinear 
relationship between alcohol consumption levels and cognitive functioning (Mukamal, Kuller, 
Fitzpatrick Longstreth, Mittleman, & Siscovick, 2003; Ruitenberg et al., 2002), implying that 
light to moderate drinking patterns may reduce the likelihood of developing AD. Recent 
prospective studies have further supported this association, with a decreased risk of AD for low 
and moderate drinkers (Weyere et al., 2011).  
In addition, the relationship between a history of heavy drinking and age of onset of AD 
has also been of recent interest. Theoretically, it can be assumed that risk factors for AD may 
affect its progression and also cause earlier onset. In a recent study by Harwood et al. (2010), 
heavy alcohol drinkers were found to have a reduced age of onset of AD by 4 years compared to 
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non-heavy drinkers. Thus, differences in history of alcohol use may be associated with either 
increased or lower age during which symptoms of AD first occur. 
 Despite a number of studies indicating a relationship of alcohol consumption to AD, 
results have been inconsistent across studies. For example, a handful of studies have reported no 
association between alcohol consumption and AD (Hebert et al., 1992; Broe et al., 1998; Graves 
et al., 1991).  However, these inconsistencies may be reflected by differences in methodology, 
such as how alcohol use is measured or length of follow-up assessment, as well as other direct 
and indirect effects that increase a person’s risk for cognitive decline. In addition, covariates 
(e.g.,, smoking, type 2 diabetes, or other vascular factors) are often adjusted to account for 
differences in outcome, and some studies may have over-adjusted for covariates that play an 
important role in the relationship between alcohol use and AD (Lobo et al., 2010; Mukamal et 
al., 2003; Anstey, Mack, & Cherbuin, 2009). Therefore, it is worthwhile to investigate how 
specific variables might place an individual at higher risk for AD, and how past alcohol use may 
moderate this relationship. 
Review of the Literature 
To better understand the potential moderating effects of alcohol consumption, it is 
important to first identify key risk factors associated with AD.  In the following pages, a review 
of risk factors for late-onset AD will be presented, which may be distinguished from early-onset 
AD that is diagnosed before the age of 65 or 60, depending on the study, and is associated with a 
strong family history and, in about 10% of cases, a specific autosomal dominant mutation 
(Wingo, Lah, Levey, & Cutler, 2012). In addition, the role of alcohol as a risk factor and as a 
protective factor will be discussed, and the potential for past alcohol use to moderate the 
relationship between AD risk factors and age of onset of AD will be addressed. 
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Risk factors for AD 
 To date, it is still unclear as to why some individuals develop late-onset AD and others 
do not. Fortunately, numerous studies have examined how various factors contribute to the 
etiology of AD and increase a person’s risk for developing the disease. A number of 
sociodemographic variables, such as increased age, female sex, and lower education have been 
associated with an increased risk of AD (Mortimer & Graves, 1993; Gao, Hendrie, Hall, & Hui, 
1998; Musicco, 2009; Letenneur et al., 1999). However, these factors have been explained 
(Hebert, Scherr, McCann, Beckett, & Evans, 2001; Stern et al., 1994) as largely due to 
differences in life expectancy or “cognitive reserve.” Therefore, it is important to evaluate the 
contribution of specific risk factors for AD within the context of an age-related or 
neurogenerative process.  
 Although the genetic influence on AD has been widely investigated, a single gene 
mutation has not yet been identified that causes late-onset AD. Rather, several lines of research 
have highlighted key neuropathological changes that may contribute to late-onset AD, including 
amyloid-beta deposits, oxidative stress, and inflammatory response (Serretti, Olgiatic, & De 
Ronchi, 2007). Of these, the ApoE gene found on chromosome 19 has been associated with risk 
of AD (Rocchi, Pelegrini, Siciliano, & Murri, 2003; National Institute on Aging, 2011). The 
three most common genetic alleles are ApoE-ε2, ApoE-ε3, and ApoE-ε4. In particular, the 
ApoE-ε4 isoform has been identified as one of the strongest genetic risk factors for late-onset 
AD (Farrer et al., 1997). Although the exact function of the ApoE-ε4 allele has not been clearly 
established, strong evidence suggests that it may involve the clearance of amyloid beta protein, 
one of the main components of amyloid plaques that are a hallmark of AD (Kim, Basak, & 
Holtzman, 2009).   
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 The ApoE-ε4 allele has been associated with differences in the progression and incidence 
of AD. For instance, it has been related to a lower age of onset in a dose-dependent manner, with 
a greater effect when both alleles are of this type (Goldstein et al., 2001; Sando et al., 2008). In 
addition, the allele has been shown to be associated with a faster rate of cognitive decline for 
individuals with AD (Craft et al., 1998), specifically AD and not other forms of dementia, such 
as vascular dementia (VaD) (Burlinson, Burns, Mann, Pickering-Brown, & Owen, 1998).  
Strong evidence supports the ApoE-ε4 allele as a genetic risk factor for AD. However, 
development of late-onset AD is not necessarily dependent on the presence of this genetic 
variation, and many individuals who are carriers of the allele do not develop the disease, and vice 
versa. Interestingly, the association of the allele with development of AD appears strongest 
before the age of 70 (Blacker et al., 1997) and may particularly affect individuals between the 
ages of 60-70 years of age (Davidson et al., 2007). Again, although the presence of the allele 
may lower the age of onset for individuals who develop AD (Khachaturian, Corcoran, Mayer, 
Zandi, & Breitner, 2004), not all carriers develop the disease. Thus, other factors may contribute 
to the lifetime susceptibility of AD.  
 Reviews of AD risk factors (Flicker, 2010; Chen, Lin, & Chen, 2009; Qiu, De Ronchi, & 
Fratiglioni, 2007) have often separated genetic or non-modifiable factors from environmental or 
modifiable factors. Of the modifiable risk factors associated with AD, strong associations have 
been found for hypertension, obesity, type 2 diabetes, heart disease, body mass index, 
cerebrovascular disease, hypercholesterolemia, alcohol consumption, and cigarette smoking, as 
well as diet and nutrition. Although many of these risk factors (e.g.,, heart disease, hypertension) 
are frequently observed in older age and may contribute to the development of AD (Rosendorff, 
Beeri & Silverman, 2007), other common pathways (e.g.,, inflammation, oxidative stress) may 
Running head: ALCOHOL USE, RISK FACTORS, ALZHEIMER’S DISEASE 
 
11
also provide a causal link. In particular, cerebrovascular pathology is one potential mechanism 
by which these factors may contribute to incident AD.  
 Factors associated with cerebrovascular disease have often been associated with AD. 
Although VaD may share several cerebrovascular pathologies to AD, AD patients can exhibit a 
significant amount of cerebrovascular pathology, with some studies (e.g.,, Tabet, Quinn, & 
Klugman, 2008) reporting up to 89% of cerebrovascular disease in patients with mild to 
moderate AD. Furthermore, these findings along with other common vascular risk factors (e.g.,, 
diabetes, hypertension, hyperlipidemia), may contribute to the pathogenesis of AD.  In a review 
of vascular factors affecting the incidence of late-onset AD, cerebrovascular factors such as 
hypertension, type 2 diabetes, smoking, and hypercholesterolemia have been cited as possible 
underlying mechanisms for AD (De Toledo Ferraz Alves et al., 2010), and further supported by 
evidence that vascular variables may contribute to cerebral atrophy and cognitive decline (Meyer 
et al., 1999, Li et al., 2011). 
 The variables discussed thus far play a significant part in the incidence of late-onset AD. 
Barnes and Yaffe (2001) estimated that several risk factors, including type 2 diabetes, smoking, 
and hypertension may be contributing factors in almost half of individuals diagnosed with AD. 
Research has now focused on the identification of modifiable risk factors that may be amenable 
to treatment and prevention (Cummings, Vinters, Cole & Khachaturian, 1998; Patterson et al., 
2008). A review by Daviglus et al. (2011) examined the effects of modifiable factors and AD 
risk. Despite significant methodological differences across studies, results suggest that type 2 
diabetes, hyperlipidemia, and smoking increase an individual’s risk for developing AD, while 
other variables such as diet, exercise, and light to moderate alcohol use may serve a more 
protective role. Thus, further research is needed to better understand how certain factors interact 
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and increase one’s risk for developing AD. Of the variables reviewed thus far, a history of 
hyperlipidemia, hypertension, and type 2 diabetes appear to be the strongest modifiable risk 
factors for late-onset AD and hold promise for future risk reduction through appropriate 
intervention.  
Modifiable risk factors. Dysfunction in cholesterol metabolism has long been associated 
with the progression of AD. An essential component of cell membranes, cholesterol is thought to 
contribute to healthy neuronal development and functioning. A number of reviews  (Lukiw, 
Pappolla, Pelaez, & Bazan, 2005; Reiss, 2005; Mathew, Yoshida, Maekawa, & Kumar, 2011) 
have suggested that dysfunction in cholesterol’s intracellular distribution and homeostasis may 
contribute to the pathogenesis of AD. For instance, hypercholesterolemia in AD individuals may 
be due to dysfunction in the transportation and excretion of cholesterol from the brain due to 
changes in the lipoprotein carrier ApoE and the synthesis of 24(S)-hydroxycholesterol. Although 
the exact mechanism between cholesterol and AD pathology is unknown, several lines of 
research have suggested that cholesterol may influence amyloid beta peptide production, 
aggregation, and clearance (Stefani & Liguri, 2009). 
Measurement of brain plasma cholesterol is particularly challenging given its high 
concentration of myelin and separation by the blood-brain barrier. As a result, much of the 
research surrounding the effects of hypercholesterolemia in AD has been derived from indirect 
evidence, including animal and cellular models of AD (Puglielli, Tanzi, & Kovacs, 2003). In one 
animal model, adult rats that were fed a cholesterol-rich diet for five months showed impaired 
memory performance as well as a number of AD-related histopathological changes, including 
cholinergic and acetylcholine dysfunction and an increased inflammatory response (Ullrich, 
Pirchl, & Humpel, 2010). Additional evidence linking AD to hypercholesterolemia comes from 
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studies investigating the use of statin medications. For instance, in cultured hippocampal 
neurons, statins have been shown to reduce the amount of cholesterol and inhibit formation of 
amyloid beta proteins (Simons, Keller, De Stropper, Beyreuther, Dotti, & Simons, 1998). 
 Results from prospective studies investigating the effects of cholesterol in AD have been 
mixed. A large, case-control study (Green et al., 2006) suggested that past use of statin 
medication significantly lowered AD risk, even after controlling for several confounding 
variables such as ApoE genotype. However, results have been inconsistent across clinical trials 
(Shepardson, Shankar, & Selkoe, 2011) and may be influenced by a number of confounding 
variables (e.g., blood brain barrier permeability, statin type). In a review and meta-analysis of 
total serum cholesterol levels and risk of dementia (Anstey, Lipnicki & Low, 2008), high midlife 
total cholesterol level was associated with increased risk for AD. However, the generalizability 
of this study is limited, given that only a total of eight studies met inclusion criteria. Additional 
longitudinal studies investigating the age-dependent association of total cholesterol and incident 
AD have varied, with some reporting an increased risk of AD for those with midlife elevated 
total cholesterol (Solomon, Kivipelto, Wolozin, Zhou, & Whitmer, 2009) and others reporting a 
lack of association (Mielke et al., 2010). Results suggest that total cholesterol may vary across 
the lifespan, and therefore other genetic and/or environmental factors may contribute to the risk 
of developing AD.  
 Hypertension has also been investigated as a potential risk factor AD. With increased 
age, hypertension is quite common and often inadequately controlled (Lloyd-Jones, Evans, & 
Levy, 2005). Changes in blood pressure and history of hypertension have been linked to AD-
related vascular pathology, including amyloid angiopathy, microvascular degeneration, blood-
brain barrier dysfunction, and white matter lesions (Jellinger, 2002; Connelly, Prentice, & 
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Fowler, 2005). However, the relative mechanism and contribution of hypertension and related 
cerebrovascular disease to incident AD has not been firmly established.   
  Although hypertension has been associated with AD-related cerebropathology, studies 
investigating the effects of hypertension and incident AD have been inconsistent. A review and 
meta-analysis of prospective cohort studies investigating the association between hypertension 
and risk of AD (Power et al., 2011) found variability across studies, and overall history of 
hypertension was not related to increased risk for AD. However, results indicated a temporal 
relationship, such that people may be at risk for AD when there is a history of high blood 
pressure before the age of 65, and decreased risk when there is a history of late-life hypertension.  
However, the temporal relationship between blood pressure fluctuations and development 
or progression of AD remains unknown. Some researchers (e.g.,, Kuyumcu et al., 2012) have 
suggested that low blood pressure may be the result of AD, and cerebral hypoperfusion may 
contribute to disease progression. On the other hand, a longitudinal study (Skoog et al., 1996) 
found that individuals with increased blood pressure at 70 years of age were at elevated risk for 
developing AD 10-15 years later. Notably, several fluctuations in blood pressure were measured 
across the study period and the relationship between low blood pressure and AD may be due to a 
cross-sectional analysis that may not be capturing the extent of blood pressure changes. Although 
blood pressure may fluctuate throughout the aging process, longitudinal studies suggest that a 
history of hypertension may nonetheless place an individual at risk for development of AD.  
Type 2 diabetes has also been associated with AD. A complex metabolic disorder, type 2 
diabetes can result in vascular changes in both peripheral (PNS) and central nervous systems 
(CNS). Some studies have suggested a potential underlying mechanism between type 2 diabetes 
and AD (Umegaki, 2010; Li & Holscher, 2007) due to a number of similarities between the two 
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diseases, including increased prevalence in older age and associated cognitive impairment. 
Although the effect of type 2 diabetes on the CNS has not been well defined, it may contribute to 
AD through chronic inflammation and dysfunction in key reparative processes in the brain 
(Taguchi, 2009). Type 2 diabetes is associated with hyperinsulinemia and insulin resistance, 
which along with impaired insulin signaling, may be associated with amyloid beta and tau 
metabolism and expression (Sims-Robinson, Kim, Rosko, & Feldman, 2010; Biessels & 
Kappelle, 2005). Thus, there may be a number of similar metabolic pathways that contribute to 
cognitive impairment in both type 2 diabetes and AD.  
Individuals with type 2 diabetes have displayed a variety of cognitive impairments 
compared to individuals without the disorder. In a systematic review of prospective studies 
investigating the association between type 2 diabetes and cognitive functioning (Cukierman, 
Gerstein, & Williamson, 2005), individuals with type 2 diabetes were shown to have a greater 
rate of cognitive decline, particularly in the domain of perceptual speed. Differences in cognitive 
functioning have also been related to risk of AD, particularly for individuals with type 2 
diabetes. Functional neuroimaging of individuals with and without type 2 diabetes has also 
suggested differences in cognitive functioning. Additionally, Hirao et al. (2011) found 
significantly decreased regional cerebral blood flow in more widespread regions for individuals 
with type 2 diabetes who also had a diagnosis of AD. Although no clear pattern of cognitive 
impairment has been indicated, results from these studies suggest that individuals with type 2 
diabetes display differences in cognitive functioning that may also increase risk for developing 
AD.   
Longitudinal studies investigating type 2 diabetes and increased risk of AD have 
provided mixed results. Some research has indicated that type 2 diabetes is not an independent 
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risk factor for AD (Akomolafe et al., 2006), and others have even suggested that it may slow 
progression of the disease (Musicco et al., 2009).  However, results from a large, prospective 
study suggests that type 2 diabetes may increase the risk of AD (Cheng, Noble, Tang, Schupf, 
Mayeux, & Luchsinger, 2011). Furthermore, the relationship between type 2 diabetes and AD 
may be magnified when the ApoE-ε4 genotype is present (Peila, Rodriguez & Launer, 2002; Irie 
et al., 2008). Therefore, although certain risk factors such as type 2 diabetes may place an 
individual at increased risk for AD, additional attention should be paid towards other factors that 
may moderate this relationship.  
Alcohol as both a risk and a protective factor. Alcohol use has also been indicated as a 
risk factor for the development of AD. In general, alcohol use is related to widespread changes in 
both PNS and CNS metabolism (Altura, Altura, Zhange & Zakhari, 1996), often exerting a 
depressant effect and decreasing overall glucose metabolism in the brain with immediate 
intoxication (Volkow et al., 2008). The effects of alcohol consumption share a number of 
commonalities with the development of AD, suggesting a possible underlying mechanism. Tyas 
(2001) highlighted that heavy or chronic drinking may be associated with brain atrophy and both 
may reduce cholinergic neurons. However, the effects of alcohol may be reversible, especially 
with increased abstinence (Bartels et al., 2006), which is not the case for AD.  
Although alcohol can have deleterious effects on the brain, consumption in lower 
quantities may be beneficial. Past studies have identified a u-shaped or j-shape curve associated 
with alcohol use and development of AD (Mukamal et al., 2003), suggesting that light to 
moderate alcohol may reduce the risk of AD in older adults. In a review of the beneficial effects 
of alcohol use, Collins et al. (2009) indicated that low to moderate consumption of a variety of 
alcoholic beverages (e.g.,, wine, beer, spirits) might serve a neuroprotective role. For example, 
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recent studies have shown that low concentrations of alcohol may protect neurons against toxic 
damage from amyloid-beta and alpha-synuclein (Bate & Williams, 2011). Others have postulated 
that AD may be the result of a neuroinflammatory process (Akiyama et al., 2000) and moderate 
alcohol use may serve an anti-inflammatory role, deterring development of the disease (Imhof, 
Froehlich, Brenner, Boeing, Pepys, & Koenig, 2001).  
Despite noteworthy neuropharmacological research, the association between the effects 
of alcohol and development of AD across epidemiologic studies has been inconclusive. In a 
review of the effects of alcohol consumption, cognitive functioning, and dementia, Panza et al. 
(2009) highlighted a number of studies that provided contrasting evidence regarding alcohol use 
as a protective factor for AD. This review also brought attention to the significant variability in 
study outcomes, with some studies identifying a link between alcohol use and AD, while others 
did not.  
Several meta-analyses have explored the contrasting evidence regarding alcohol 
consumption and risk of AD. In general, these studies (e.g.,, Peters, Peters, Warner, Beckett, & 
Bulpitt, 2008) all found a relationship between low to moderate alcohol use and lower risk of 
cognitive decline. Neafsey and Collins (2011) conducted a large review and meta-analysis of 
studies investigating the relationship between moderate alcohol consumption and cognitive 
functioning. Two phases or “eras” of research were highlighted, including an initial period 
before 1997 that involved assessment of mainly young and middle aged adults and another 
period after 1997 that involved mental status examinations of mostly older adults. In the initial 
era, most studies found a relationship between a history of heavy drinking and cognitive 
impairment, but low or moderate alcohol use was not associated with performance on cognitive 
tasks. Approximately 80% of the studies reviewed took place in the second phase, and a meta-
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analysis of these studies revealed that, compared to abstainers, moderate drinkers had a 
decreased risk of AD. Across studies, adjustment for several confounding variables such as age, 
education, sex, and smoking did not change these results, although adjustment for ApoE-ε4 allele 
resulted in a non-significant relationship. Therefore other factors may influence the relationship 
between moderate alcohol use and risk of AD.  
Although meta-analyses have been helpful in examining the variability in results across 
studies of alcohol consumption and development of AD, a number of limitations remain. For 
example, comprehensive reviews and meta-analyses often report a significant amount of 
heterogeneity across studies, limiting generalizability of results. In both meta-analyses discussed 
(Neafsey et al., 2011; Peters et al., 2008) differences in study outcomes may have been 
influenced not only by methodological limitations, but also by genetic and non-genetic factors 
that may not have been considered. And, even when certain confounding variables are examined 
(e.g.,, ApoE-ε4 allele), there may not be enough evidence to support a relationship between 
alcohol use and risk of AD. Thus, further examination of risk factors is needed. Particular 
attention should be paid towards genetic and non-genetic factors that may interact with alcohol 
use and development of AD.   
In sum, a variety of risk factors have been identified for AD. Many of these variables are 
purported to share common pathologic mechanisms (Martins et al., 2006) and interact with one 
another to influence the development of AD. For instance, factors such as type 2 diabetes, 
hyperlipidemia, and hypertension all affect the vascular system. Moreover, the presence of key 
sociodemographic differences (e.g.,, age, sex) interact with these risk factors (Jarvik, Wijsman, 
Kukull, Schellenberg, Yu, & Larson, 1995). However, despite a plethora of evidence relating 
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several risk factors to AD, the mechanism by which these factors interact and increase an 
individual’s risk for developing the disorder is still unknown. 
Some evidence suggests that certain variables may moderate the relationship between 
other risk factors and AD. For example, the presence of the ApoE-ε4 allele has been shown to 
increase cognitive decline and dementia in the context of other vascular factors, including high 
blood pressure and type 2 diabetes (Haan, Shemanski, Jagust, Manolio, & Kuller, 1999; Irie et 
al., 2008). When examined in the context of heavy alcohol consumption (i.e. greater than 2 
drinks per day), ApoE-ε4 allele further increases the risk of AD at a lower age (Harwood et al., 
2010). Although results from this study provided evidence that a history of heavy drinking may 
accelerate the disease process, there was no investigation of risk associated with low or moderate 
drinking. Therefore, additional research is needed to better understand how differences in alcohol 
consumption patterns serve as a potential moderator variable in the development of AD.  
Alcohol consumption as a moderator variable. Although heavy drinking has often been 
associated with increased risk of AD, recent data suggests that low to moderate alcohol 
consumption may actually decrease risk. Given that a variety of genetic and non-genetic factors 
may interact with alcohol consumption (Sinforiani et al., 2011), it is possible that alcohol’s 
effects may interact with other risk factors to moderate the development of AD. Several studies 
have investigated how specific vascular factors relate to alcohol consumption patterns as well as 
risk of AD. Type 2 diabetes and hypertension have often been linked to alcohol consumption 
patterns. For example, a history of heavy drinking increases the risk for hypertension (Saremi et 
al., 2003), and a meta-analysis of randomized controlled trials reported that a reduction in 
alcohol use might reduce systolic and diastolic blood pressure (Xin et al., 2001). Moderate 
alcohol consumption also has been associated with a lowered risk of developing type 2 diabetes 
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(Koppes et al., 2005). It is therefore possible that alcohol consumption patterns may moderate 
the relationship between other risk factors such as hypertension and type 2 diabetes and risk for 
the development of AD. 
Additional evidence that alcohol consumption may act as a moderating variable has 
arisen from studies adjusting for specific covariates. Although study variables are often 
controlled in order to account for differences in outcome, some (e.g.,, ApoE-ε4 allele, type 2 
diabetes, other vascular factors) may interact with alcohol consumption as part of a causal 
relationship that influences the development of AD. A recent meta-analysis (Anstey et al., 2009) 
of prospective studies of alcohol use, cognitive decline, and dementia found that a history of 
light to moderate drinking was associated with a 25% reduced risk of incident AD. Notably, 
several studies adjusted for covariates, and in some cases, this adjustment increased the effect 
size.  
Upon closer examination of studies that adjust for covariates, there was significant 
heterogeneity in terms of methodology and adjusted analyses. For example, some (e.g., Espeland 
et al., 2004) combined covariates for adjustment analyses, which may have overshadowed the 
impact of specific variables on alcohol consumption and AD. A prospective study by Deng et al. 
(2006) found significant differences at baseline between alcohol consumption and a number of 
confounding variables (e.g., blood pressure, stroke, smoking, age, gender). Although there was 
no follow-up data collected, baseline differences between drinking patterns and other risk factors 
may have affected the relationship between risk factors and the development of AD. Therefore, 
examination of the interaction between specific, individual covariates is necessary to address the 
possible moderating role of alcohol consumption.  
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Additional prospective studies of incident AD suggest that specific covariates may 
interact with various alcohol consumption patterns. Mukamal et al. (2003) found that mild-
moderate drinking (i.e.,1-6 drinks per week) was related to a decreased risk of dementia overall, 
including AD. Sensitivity analyses indicated that, for moderate-heavy drinkers (i.e., 7-13 drinks 
per week), cholesterol and fibrinogen levels (a plasma glycoprotein associated with 
cerebrovascular disease and inflammation at high concentration) accounted for approximately 
16% lower risk of dementia; presence of the ApoE-ε4 genotype appeared to moderate this 
association, especially for heavy drinkers (i.e., greater than 14 drinks per week). An additional 
prospective study further confirmed the relationship between ApoE-ε4 allele, alcohol 
consumption, and risk of AD (Luschinger, Tang, Siddiqui, Shea, & Mayeux, 2004), suggesting 
that the protective role of moderate alcohol use may be confined to individuals without the 
ApoE-ε4 genotype. Other possible covariates, including type 2 diabetes and hypertension, did 
not appear to modify the relationship between alcohol use and incident AD. However, the sample 
may have lacked sufficient numbers of heavy and moderate drinkers, which may have obscured 
this association.  
Overall, a number of genetic and environmental risk factors may interact to influence the 
development of AD. Lower age of onset of the disease has been strongly related to genetic 
susceptibility (i.e., the presence of the ApoE-ε4 allele). However, other risk factors including a 
history of heavy drinking may also contribute to a lower age of onset (Rao et al., 1995).  
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Conclusion and Purpose of Current Study 
 In sum, there is a large body of evidence to suggest that the presence of the ApoE-ε4 
allele, as well as history of hypertension, hyperlipiedemia, and type 2 diabetes, increase an 
individual’s risk for developing AD. Although a history of heavy drinking is also known to be a 
risk factor, recent evidence suggests that alcohol at low or moderate doses may serve a protective 
function. Of the numerous studies that have investigated the association between alcohol 
consumption and onset of AD, studies overall have been limited by differences in methodology 
and differences in how alcohol consumption patterns and cognitive decline are assessed, as well 
as low sample sizes. In addition, much heterogeneity across studies may stem from the 
interaction of other risk factors that influence the development of AD. Often, these risk factors 
are adjusted for in analyses, however they may also have an important part in the development of 
AD. Low to moderate rates of alcohol consumption may serve as a protective factor by slowing 
age of onset of AD, while higher rates of consumption may increase risk. Few studies have 
specifically evaluated differences in alcohol consumption patterns in moderating the relationship 
between other risk factors and AD. Therefore, the purpose of the current study is to examine how 
past alcohol use interacts with other known risk factors (e.g., type 2 diabetes, ApoE-ε4 allele, 
hyperlipidemia, and hypertension) in the development and age of onset of AD.  
Statement of the Hypotheses 
Hypothesis 1. A positive past history of type 2 diabetes, hypertension, hyperlipidemia, 
and presence of ApoE-ε4allele are expected to be positively associated with risk of AD. In 
particular, persons with a history of these risk factors are expected to have a significantly lower 
age of onset of AD compared to those without these risk factors.   
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Hypothesis 2. It is expected that history of alcohol use will moderate the relationships 
between individual risk factors and age of onset of AD, such that a history of type 2 diabetes, 
hypertension, hyperlipidemia, or presence of ApoE-ε4 allele will be more strongly related to a 
lower age of onset of AD when there is history of heavy alcohol use than when there is a history 
of low/moderate alcohol use.  
Method 
Participants and Setting  
Participants were community-dwelling older adults already enrolled as either subjects in 
longitudinal study of aging or as patients at the Layton Aging and Alzheimer’s Disease Center at 
Oregon Health and Science University located in Portland, Oregon. Study data was collected 
from an existing database of participants’ visits. For a detailed description of the collection and 
storage of study data, see Morris et al. (2006) and Beekly et al. (2007). Data from participants 
were included in the present study if they met the following criteria: aged 65-88 with a diagnosis 
of possible AD or probable AD, and availability of the following information in the dataset: age 
of onset of AD, ApoE-ε4 allele type, history of type 2 diabetes, hypertension, and 
hyperlipidemia, smoking, and past alcohol use. From the database, a total of 307 individuals met 
inclusion criteria. A total of 173 females (56.4%) and 134 males (43.6%) composed this sample. 
Average participant age at baseline was 77.42 (SD = 6.55). The majority of participants 
identified as being Caucasian (95.7%), while 4 % reported being African-American/Black and 
0.3% reported being Asian. Most individuals (70%) reported completing 12 to 16 years of 
education, while 18.9% reported completing greater than 16 years and 11.1% reported 
completing less than 12 years of education. 
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Research Design and Procedure. The study was approved by OHSU and Pacific 
University’s institutional review boards prior to requesting data variables. Following approval, 
the following variables were requested:  
Demographic information and covariates. Participant’s age (65-88 years of age), gender 
(coded as 0 = male, 1 = female), race (coded as 1 = Caucasian, 2 = Black/African American, 3 = 
Asian), and level of educational achievement were collected from the database. Past history of 
smoking (coded as 0 = negative history, 1 = positive history) and number of head injuries were 
collected as covariates.  
Predictor and outcome variables. Presence of ApoE-ε4 allele, as well as history of type 2 
diabetes, hypertension, and hyperlipidemia were collected as predictor variables. Age of onset of 
AD, when present, was collected as the outcome variable. Alcohol use history was collected 
from a visit summary in which the participant or collateral source (e.g., a caretaker) was asked to 
describe the participant’s past alcohol use. The Alcohol Use Disorders Identification Test 
(AUDIT-QF) is a measure that assesses quantity and frequency of alcohol use, and is comprised 
of the following questions: how often do you have a drink containing alcohol and how many 
drinks do you have on a typical day when you are drinking? The AUDIT-QF was used for the 
current study to categorize the patient’s self-report of alcohol use from clinic visits. Therefore, 
the initial data from the patient’s clinic visit describing alcohol use history was coded and 
transformed as a continuous variable based on this measure. Total scores range from 0-8, with 
heavy drinking classified by scores greater than 4 points (Aalto, Tuunanen, Silanaukee, & Seppa, 
2006) and light/moderate drinking classified by scores ranging from 1-3 points. Non-drinkers 
had 0 points. 
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Results 
Data Cleaning 
 Before analyzing the data, each of the variable’s compliance with univariate and 
multivariate assumptions was examined using SPSS 18.0 (SPSS Inc., 2009). A total of 336 
datasets from the initial database had the available demographic, predictor and outcome 
variables; however, 29 datasets had incomplete or limited alcohol use history and these were 
removed from analysis. The Mahalanobis distance test was conducted to assess for multivariate 
outliers. Using a conservative cut-off of p<0.001, 8 outliers were detected and these datasets also 
were removed from the sample. This resulted in a final sample of 299 (see Table 1 for 
demographic information of excluded participants and Table 2 for the demographic information 
of the final sample). Upon inspection of the distribution of scores of the final sample, history of 
diabetes and number of head injuries were significantly skewed and kurtotic; therefore, these two 
variables were excluded from the final analysis.  In all, the total number of datasets in which the 
patient had a history of diabetes was 22, and the total number of datasets in which the patient had 
a history of head injury was 47 (41 with at least 1 head injury and 6 with at least 2 head injuries).  
 
 
 
Table 1
Reason for Exclusion n Sex
10 Males
19 Females
Outliers 8 3 Males
5 Females
Insufficient Information 
about Past Alcohol Use 29 75.71 (6.32)
34 White
3 Black
Demographic Characteristics of the Participants Excluded (N = 37)
Age (SD)  Race
2 Black
1 Asian
0 Asian
75.16 (6.77) 5 White
Education (range)
4 (<12)
10 (12-16)
 5 (>16)
1 (<12)
5 (12-16)
2 (>16)
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Table 2 
Demographic Characteristics of the Final Sample (N = 299) 
Variable n (%) Range Median M (SD) 
Age (years) 299 (100) 23 77.60 77.43 (6.55) 
Sex                                  Male 131 (43.8) 
Female 168 (56.2) 
Race                             White 290 (97.0) 
African-American/Black 9 (3.0) 
Asian 0 (0) 
Education                          <12 33 (11.04) 
12-16 211 (70.57) 
>16 55 (18.39) 
 
Distribution of Variables and Descriptive Statistics  
 Descriptive statistics, including the mean and standard deviation for age of onset of AD, 
as well as frequency of alcohol use and additional variables, are provided in Table 3. 
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Table 3 
 
Means, Standard Deviation, Frequency, Skewness, and Kurtosis by Variable 
Variable  Mean (SD)  Frequency (%)  Skewness (SE)  Kurtosis (SE) 
              
Age AD*  78.408 (6.90)  -.157 (.141)  -1.19 (0.281) 
Alcohol Use   0.143 (0.141)  -1.86 (0.281) 
0  125 (41.8) 
1-3  147 (49.2) 
>4  27 (9) 
Hypertension  0.292 (0.141)  -1.928 (0.281) 
Yes  128 (42.8) 
No  171 (57.2) 
Hyperlipidemia  1.426 (0.141)  0.034 (0.281) 
Yes  63 (21.1) 
No  236 (78.9) 
APOE4  0.155 (0.141)  -1.989 (0.281) 
Yes  138 (46.2) 
No  161 (53.8) 
Smoking  -0.39 (0.141)  -1.86 (0.281) 
Yes  178 (59.5) 
No     121 (40.5)       
* Age AD = Age at AD diagnosis. 
A hierarchical multiple regression analysis was performed; results are provided in Table 
4. Demographic variables and covariates were added at step one. Together, the total effect was 
statistically significant and contributed to unique variance in the model (∆R^2 = .922, p < 0.00).  
However, when examined individually, only male sex (β = 0.038, and p = 0.03), age at baseline 
(β = 0.963 and p < 0.00), and years of education (β = 0.963 and p < 0.011) were significant 
positive predictors for age of onset of AD. Risk factors were added at step two. The total effect 
was statistically significant and contributed to an additional .07% of unique variance in the 
model (∆R^2 = .007, p < 0.00). Of the risk factors, alcohol use history (β = 0.040 and p = 0.019) 
and hyperlipidemia (β = 0.068 and p < 0.00) were significant positive predictors of age of onset 
of AD. However, other risk factors (i.e., hypertension, ApoE-ε4 allele) did not predict age of 
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onset of AD. Alcohol use history x risk factors was added at step three. Together, these 
interactions were statistically significant and accounted for an additional 0.03% of the variance 
in age of onset of AD (∆R^2 = .003, p < 0.005). When each interaction was examined 
individually, hypertension and alcohol use history were statistically significant and positively 
predictive of age of onset of AD (β = 0.078 and p < 0.005). There were no additional statistically 
significant interactions.  
 In order to evaluate the interaction between history of hypertension and alcohol use, a 
simple slope analysis was used to plot age of onset of AD regressed onto hypertension at high 
(+1 SD) and low (-1SD) values of alcohol use history (see Figure 1). A statistically significant 
relationship was found between age of onset of AD and history of high alcohol use (β = 4.55, t = 
4.16, p <0.00), whereas there was no statistically significant relationship between age of onset of 
AD and history of low alcohol use (β = 1.22, t = 1.12, p = 0.27). 
Overall, results indicate that sex and age at baseline were significantly predictive of age 
of AD onset in the context of several risk factors for AD. Although level of education was 
positively predictive of AD onset, it was non-significant after additional risk factors were 
considered.  Alcohol use history was also significantly predictive of age of AD onset when 
additional risk factors were included (step 2), but was not significant once the interaction 
between alcohol use and risk factors were considered (step 3). With regards to the first 
hypothesis, only history of hyperlipidemia was positively predictive of age of onset of AD. No 
other risk factors were associated with age of onset of AD. With regards to the second 
hypothesis, alcohol use history moderated the relationship between history of hypertension and 
age of AD onset. There were no additional significant moderating effects.  
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Table 4 
 
Regression Analysis Predicting Age of AD Diagnosis from Alcohol Use, Hypertension, 
Hyperlipidemia, ApoE-ε4 allele, Smoking, and Demographic Variables 
Predictor        β  ΔR^2  FΔ  p 
                    
Step 1  0.921  678.436  0.000 
Age  0.962  0.000 
Race  0.017  0.304 
Sex  0.038  0.030 
Education  0.044  0.011 
Smoking  0.014  0.412 
Step 2  0.007  6.646  0.000 
Age  0.963  0.000 
Race  0.013  0.412 
Sex  0.037  0.032 
Education  0.028  0.095 
History Smoking  -0.003  0.866 
Alcohol 
Use  0.040  0.020 
Hypertension  0.016  0.333 
Hyperlipidemia  0.069  0.000 
APOE4  -0.011  0.502 
Step 3  0.003  4.367  0.005 
Age  0.959  0.000 
Race  0.014  0.375 
Sex  0.040  0.017 
Education  0.028  0.088 
History Smoking  -0.002  0.897 
Alcohol 
Use  0.008  0.779 
Hypertension  -0.032  0.180 
Hyperlipidemia  0.051  0.036 
APOE4  0.009  0.697 
Alcohol x Hypertension  0.080  0.004 
Alcohol x Hyperlipidemia  0.032  0.217 
Alcohol x APOE4     -0.035        0.195 
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Table 5 provides zero-order (bivariate) correlations between variables. Age at baseline was 
negatively correlated with education (r = -0.150, p = .009) and presence of ApoE-ε4 allele (r = -
0.195, p = 0.001), and positively correlated with age of onset of AD (r = 0.956, p = 0.000) and 
hypertension (r = 0.193, p = 0.001). Male sex was negatively correlated with history of smoking 
(r = -0.261, p < 0.000) and alcohol use history (r = -0.164, p = 0.004). Years of education was 
negatively correlated with male sex (r = -0.210, p < 0.000) and positively correlated with alcohol 
use history (r = 0.206, p <0.000). History of smoking was positively correlated with alcohol use 
history (r= 0.262, p < 0.000). Age of onset of AD was positively correlated with history of 
hypertension (r = 0.219, p < 0.000) and negatively correlated with presence of ApoE-ε4 allele (r 
= -0.204, p < 0.000). 
Table 5 
Intercorrelations Between Variables 
 
**Correlation is significant at the 0.01 level (2-tailed). Age = Age at baseline, Age AD = Age of 
AD Onset, Alc = Alcohol Use, HN = Hypertension, HL = Hyperlipidemia, APOE4 = ApoE-ε4 
allele. 
 
 
Age Race Sex Education Smoking Age AD Alcohol Use HN HL APOE4
Age -- -- -- -- -- -- -- -- -- --
Race 0.007 -- -- -- -- -- -- -- -- --
Sex 0.065 -0.042 -- -- -- -- -- -- -- --
Education -0.150** -0.089 -0.210** -- -- -- -- -- -- --
Smoking -0.015 -0.014 -0.261** 0.032 -- -- -- -- -- --
Age AD 0.956** 0.170 0.090 -0.109 -0.015 -- -- -- -- --
Alc -0.132 -0.009 -0.164** 0.206** 0.262** -0.088 -- -- -- --
HN 0.193** 0.045 0.069 -0.027 0.080 0.219** 0.043 -- -- --
HL -0.059 0.005 -0.023 0.116 0.075 0.014 0.056 0.100 -- --
APOE4 -0.195** -0.124 -0.088 0.037 -0.002 -0.204** -0.015 -0.42 0.065 --
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Figure 1. Simple slope for history of hypertension in the prediction of age of AD diagnosis at 
low (-1 SD) and high (+1 SD) values of alcohol use. The values for history of hypertension and 
alcohol use are centered to have a mean of zero.  
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Discussion  
The purpose of this dissertation was to assess whether alcohol use history moderates the 
relationship between certain risk factors (i.e., hypertension, hyperlipidemia, ApoE-ε4 allele) and 
age of onset of AD. Inconsistent with the first hypothesis, the only risk factor that was predictive 
of age of onset of AD was hyperlipidemia. Furthermore, the results of the current study partially 
support the second hypothesis and suggest that alcohol use may moderate the relationship 
between history of hypertension and age of AD onset. Alcohol use history did not appear to 
moderate the relationship between other risk factors. 
A number of sociodemographic variables, including age, sex, and education, were 
positively predictive of age of onset of AD. Specifically, being male and having a lower 
education were predictive of a lower age of onset. However, when additional risk factors and 
alcohol use history were considered, only age at baseline and sex remained predictive of age of 
AD onset. This study strengthens current research and suggests that men may develop AD earlier 
than women, even after adjusting for several risk factors. However, it is important to note that 
several studies have only found higher incidence rates in females who were older than 90 years 
of age (Jorm & Jolley, 1998; Ruitenberg, Ott, van Swieten, Hofman, & Breteler, 2001) and that 
any gender-related risk factors may be attributed to differences in life expectancy (Hebert et al., 
2001). In addition, the finding that age at baseline visit was positively correlated with age of AD 
onset may reflect a methodological limitation. In this study, the reported age of onset may have 
also been collected during the first clinic visit when diagnosis was made at that time, which was 
then confounded with age at baseline. Research has consistently shown the opposite finding; in 
fact, age has been shown to be the single greatest predictor of the development of AD 
(Alzheimer’s Association, 2013). 
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The relationship between risk factors and age of onset of AD were mixed and generally 
did not support the first hypothesis. Initial correlations indicated that history of hypertension was 
positively correlated with age of AD onset and that presence of ApoE-ε4 allele was negatively 
correlated with age of AD onset. The negative correlation between the ApoE-ε4 and age of AD 
onset is also consistent with previous research, which suggests that the presence of this risk 
factor may correlate with a lower age of onset of AD. However, when considering additional 
demographic and risk factors, the presence of the ApoE-ε4 was not predictive of age of onset of 
AD. Interestingly, only history of hyperlipidemia was positively predictive of age of onset of 
Alzheimer’s disease. This paradoxical finding may be due to a number of factors, including the 
possible differential impact of hyperlipidemia in early versus late-life. A number of studies have 
found that individuals with hyperlipidemia in midlife may have increased risk for AD (Solomon 
et al., 2009; Anstey et al., 2008). However, our results strengthen previous findings from Meilke 
et al. (2005), who found that individuals with high total cholesterol levels at age 70 had a lower 
risk of developing AD in later life; these findings were also explained in terms of differences in 
frailty, such that individuals who survived the negative health consequences associated with 
hyperlipidemia in mid-life were less likely to develop dementia later. Additional evidence of 
hyperlipidemia history for providing a survival, rather than a protective, effect comes from West 
et al. (2008), who found that cholesterol levels were positively associated with memory 
performance in non-demented, very elderly individuals.  These findings suggest that very elderly 
individuals may perform better on cognitive testing not necessarily because of a history of high 
cholesterol, but rather, that these individuals were able to survive and overcome the negative 
health consequences associated with high cholesterol. Furthermore, elderly individuals with a 
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history of high cholesterol who also perform better on memory tests than their elderly 
counterparts, may be less frail and are better able to recover from chronic health conditions.   
Although alcohol use history was not significantly correlated with age of AD onset in 
itself, results suggest that alcohol use is positively predictive of age of onset of AD in the context 
of additional demographic and risk factors. These results suggest that alcohol use, by itself, may 
not impact the development of AD but rather may interact with additional factors that influence 
the disease process. Consistent with hypothesis two, alcohol use appeared to moderate the 
relationship between history of hypertension and age of AD onset, such that when there is a 
history of higher levels of alcohol use, the relationship between age of AD onset and history of 
hypertension is stronger than when there is a history of low alcohol use. 
Overall, these results suggest that alcohol use may serve both as a protective and a risk 
factor for individuals with history of hypertension. This appears to be is the first study to date 
that has shown a moderating effect of alcohol use on age of onset of AD for individuals with a 
history of hypertension. These results are not surprising given that alcohol usage has been shown 
to have a linear relationship with hypertension, such that a reduction in alcohol use may decrease 
blood pressure (Xin et al., 2011). However, the mechanism by which hypertension may impact 
the development of AD and, by extension, how alcohol usage may further moderate this 
relationship, is unknown. Several studies have suggested that hypertension may impact a number 
of cerebrovascular changes that underlie the AD process, including changes in blood vessel walls 
and breakdown of the blood-brain barrier (e.g., Jellinger, 2002). Recently, an animal study by 
Carnevale et al. (2012) demonstrated that, through oxidative stress induction, chronic 
hypertension leads to activation of the receptor for advanced glycation endproducts (RAGE), 
which resulted in B-amyloid deposition and cognitive decline similar to AD pathology. It is 
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hypothesized that higher alcohol use in the current study may have increased the effects of 
hypertension as a risk factor for AD and that lower alcohol use may reduce these effects, 
possibly through moderating differential effects of oxidative stress.  
 The current study has several limitations. First, this study was cross-sectional in nature, 
and therefore causal interpretations about the results cannot be made. The method by which risk 
factors were assessed also presented a number of limitations. In particular, history of risk factors 
were assessed by self-report or from caretaker, and direct assessment was not available. Also, the 
absence of certain risk factors, such as alcohol use, cannot be certain based on retrospective 
report, and the presence of low alcohol use for at least some datasets in the current study may 
reflect limits to accurate data collection in this area rather than actual low use by some patients. 
Additionally, all of the risk factors in this study were analyzed for mere presence or absence for 
each participant. Therefore, differences in onset/time since diagnosis and severity of specific risk 
factors were unavailable, and results should be interpreted within this context.  As a whole, the 
sample was predominantly White and well-educated, which further limits the generalizability of 
findings. In addition, the type of alcohol consumed (e.g., beer, spirits, wine) was not considered, 
and some research suggests that wine may be more beneficial than other types of alcohol 
(Luchinsger et al., 2004). 
History of medication, used for treating several of these risk factors was not taken into 
account and could significantly impact the results from the study. For example, a number of 
individuals with history of hypercholesterolemia may have also been taking statin medications, 
which could impact the development of AD. Specifically, there is some evidence to suggest that 
lipid-lowering medications may serve a protective role (Rodriguez, Dodge, Birzescu, Stoehr, & 
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Ganguli, 2002; Zamrini, McGwin, & Roseman, 2004), although other studies have found a lack 
of association or inconclusive results due to methodological differences (Li et al., 2004).  
It is also important to mention that, even though hypertension and age-related increases in 
blood pressure are common in older age (e.g., Franklin et al., 1997), there is general fluctuation 
and variability in blood pressure (e.g., Skoog et al. 1996). Recently, a study by Alperovitch et al. 
(2013) found that blood pressure variability, rather than hypertension in and of itself, increased 
an individual’s risk for incident AD. Therefore, future studies may consider evaluating whether a 
history of low to moderate alcohol use may function to stabilize blood pressure variability and 
protect against the development of AD.  
 Overall, the current study has a number of strengths, including a large sample size and 
good sensitivity of AD diagnosis (see Beach, Monsell, Phillips, & Kukull, 2013 for more 
information), this study also focused on age of onset to investigate increased risk for 
development of AD, which can be a better indictor than other methods such as brief cognitive 
assessment (Clark et al., 1999). Future studies should continue to assess the impact of modifiable 
factors that could delay the onset of AD, as this has the potential to significantly impact 
prevalence rates and economic burden (Brookemeyer, Gray, & Kawas, 1998). Furthermore, 
given that several risk factors for AD are chronic, future research should focus on participatory 
medicine, such as how patient engagement in treatment of chronic diseases may impact the 
development of AD.  
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